Manufactures pharmaceutical-grade hyaluronic acid for medical purposes.
May 2025Revenue $129M/yrExpenses $146M/yr
No trendCash runway ≈ 1.3 years from Jun 2026
Figures by year
When will Lifecore Biomedical, Inc. de be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to May 2025, revenue was $129M and expenses $146M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| May 2025 | $129M | $146M | −$17.2M |
| May 2024 | $128M | $137M | −$8.84M |
| May 2023 | $103M | $125M | −$21.8M |
| May 2022 | $111M | $123M | −$11.8M |
| May 2021 | $101M | $110M | −$8.82M |
| May 2020 | $160M | $186M | −$25.9M |
| May 2019 | $558M | $552M | $5.47M |
| May 2018 | $524M | $511M | $13.6M |
| May 2017 | $470M | $455M | $14.7M |
| May 2016 | $477M | $498M | −$20.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.